Shares of HIMS experienced a dramatic slump today following the unexpected termination of its agreement with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending its stock price plummeting by over 20%. The reason for the breakdown of the partnership remains unclea